The P-I study is assessing the bioavailability, PK/PD, safety & tolerability of furosemide (80mg/mL) SC vs IV (two 40mg) given over 1-to-2 mins., in a difference of 2hrs. among healthy subjects (n=21, 45-80yrs.) 

The study showed a bioavailability of 107.3%, comparable urine output, urinary sodium & potassium excretion at 6, 8 & 12hrs. and a median pain score of 0 at all evaluated time points. Data will be highlighted at upcoming conferences 

scPharmaceuticals is expecting sNDA submission to the US FDA during YE’24